OncoImmunology

Titel Veröffentlichungsdatum Sprache Zitate
Consensus guidelines for the detection of immunogenic cell death2014/09/02English569
Radiation fosters dose-dependent and chemotherapy-induced immunogenic cell death2014/04/01English377
CSF1R inhibition delays cervical and mammary tumor growth in murine models by attenuating the turnover of tumor-associated macrophages and enhancing infiltration by CD8+T cells2013/12/01English283
IDO inhibits a tryptophan sufficiency signal that stimulates mTOR: A novel IDO effector pathway targeted by D-1-methyl-tryptophan2012/12/01English274
Targeting PD-1/PD-L1 interactions for cancer immunotherapy2012/11/01English269
Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy2014/05/01English257
TIM3+FOXP3+regulatory T cells are tissue-specific promoters of T-cell dysfunction in cancer2013/04/01English224
Dendritic cell exosomes directly kill tumor cells and activate natural killer cells via TNF superfamily ligands2012/10/01English216
A CD38/CD203a/CD73 ectoenzymatic pathway independent of CD39 drives a novel adenosinergic loop in human T lymphocytes2013/09/01English197
Myeloid derived suppressor cells—An overview of combat strategies to increase immunotherapy efficacy2015/01/02English187
Are natural killer cells superior CAR drivers?2014/04/01English183
Distinct patterns of intratumoral immune cell infiltrates in patients with HPV-associated compared to non-virally induced head and neck squamous cell carcinoma2015/01/02English176
Trial watch2012/11/01English176
Insufficient autophagy promotes bronchial epithelial cell senescence in chronic obstructive pulmonary disease2012/08/01English171
The IRF family of transcription factors2012/11/01English166
Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy2012/09/01English165
Trial watch: IDO inhibitors in cancer therapy2014/09/01English162
Trial Watch2012/08/01English159
Exomics and immunogenics2014/01/01English156
OX40 costimulation by a chimeric antigen receptor abrogates CD28 and IL-2 induced IL-10 secretion by redirected CD4+T cells2012/07/01English143
High endothelial venules (HEVs) in human melanoma lesions2012/09/01English142
Phase I study of the CD40 agonist antibody CP-870,893 combined with carboplatin and paclitaxel in patients with advanced solid tumors2013/01/01English141
Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy2014/11/03English139
γδ T cells for cancer immunotherapy2014/01/01English138
Neutrophil extracellular traps2013/02/01English137
Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy2013/08/01English135
Retargeting NK-92 cells by means of CD19- and CD20-specific chimeric antigen receptors compares favorably with antibody-dependent cellular cytotoxicity2013/10/01English134
Electrochemotherapy with bleomycin induces hallmarks of immunogenic cell death in murine colon cancer cells2014/04/01English134
TIL therapy broadens the tumor-reactive CD8+T cell compartment in melanoma patients2012/07/01English129
Adverse events to monoclonal antibodies used for cancer therapy: Focus on hypersensitivity responses2013/10/01English125